Sale!

Zolmitriptan

A$0.00

-17%
Zolmitriptan is a medication used to help relieve migraine headaches. It works by narrowing blood vessels around the brain and reducing substances in the body that can trigger migraine symptoms. Zolmitriptan can help relieve pain, nausea, and sensitivity to light and sound. It is most effective when taken at the first sign of a migraine. Always use this medicine as directed by your doctor or pharmacist.

Zolmitriptan – Patient Information for Australia

Basic Product Information

International Nonproprietary Name (INN) Zolmitriptan
Brand Names in Australia Zomig®, Zomig Rapimelt®
ATC Code N02CC03
Available Forms & Strengths
  • Tablets: 2.5 mg, 5 mg
  • Orodispersible (Rapimelt) tablets: 2.5 mg, 5 mg
Manufacturers AstraZeneca, Teva Pharma, generic manufacturers
Prescription Status Prescription only (Schedule 4; S4 drug)

Mechanism of Action

For patients: Zolmitriptan belongs to a group of medicines called “triptans,” commonly used for the relief of migraine attacks. It works by narrowing widened blood vessels in the brain and blocking pain signals that trigger the symptoms of a migraine.

For specialists: Zolmitriptan is a selective 5-HT1B/1D receptor agonist, producing vasoconstriction of intracranial arteries and inhibiting trigeminal nerve transmission of pro-inflammatory neuropeptides (CGRP, substance P). This dual mechanism effectively interrupts migraine pathophysiology.

Pharmacokinetics

  • Absorption: Rapid, with peak plasma concentration reached within 1–2 hours (Rapimelt acting slightly faster).
  • Metabolism: Hepatic, primarily by CYP1A2 to active metabolite (N-desmethyl-zolmitriptan).
  • Elimination: Mostly urinary; terminal half-life approx. 3 hours.
  • Duration of action: Typically provides relief within 1 hour; effects last 4–6 hours.

Use in Everyday Life and Best Practices

Zolmitriptan is primarily used as an acute treatment for migraine with or without aura, not for migraine prevention. It should be taken at the start of a migraine attack, ideally when symptoms begin but before the headache intensifies.

  1. Dose: Adults usually take one 2.5 mg tablet (may increase to 5 mg if insufficient relief).
  2. How to use: Swallow oral tablets with water. For Rapimelt (orodispersible), place on tongue where it dissolves without water—ideal if nausea or vomiting is present.
  3. If symptoms return: You may repeat the dose after 2 hours if your migraine recurs. Do not exceed 10 mg in 24 hours.
  4. Children: Not generally recommended unless specifically advised by a specialist.
  5. Elderly: Caution required; same dose as adults unless advised otherwise.

Dosing in the Morning vs Evening

  • Morning Dose: Many patients experience migraines in the morning, so taking Zolmitriptan at attack onset is most effective. This helps restore work/school activities.
  • Evening Dose: Can be used for attacks occurring in the evening. Be aware that the sedative side effects may cause drowsiness.
  • Tips on Regularity: Zolmitriptan is not for scheduled daily use—take only as needed for migraines. Keep tablets accessible at all times (handbag, bedside, work desk).

Taking with Food or on an Empty Stomach

  • Zolmitriptan works equally well with or without food. Food may slightly delay absorption but does not reduce effectiveness.
  • If you experience nausea, the Rapimelt (orodispersible) tablet version is easier to take without needing water—ideal for the typical nausea of migraine attacks.
  • Fits well with typical English dietary habits; no restrictions on bread, tea, or common meals.

Interaction Warnings

Interaction Details / Recommendations
Other migraine medicines (ergotamine, sumatriptan, rizatriptan, etc.) Do not take within 24 hours of another triptan or ergot-based drug.
SSRIs, SNRIs, MAOIs Combining can increase risk of serotonin syndrome. Avoid or use only under medical supervision.
Antidepressants (mirtazapine, tricyclics) Increased risk of adverse reactions; monitor for serotonin syndrome symptoms.
St John’s Wort May increase side effects; discuss with pharmacist/doctor before use.
CYP1A2 Inhibitors (e.g., cimetidine, fluvoxamine) May increase zolmitriptan levels. Dosage adjustment may be necessary.
Alcohol Alcohol can worsen migraine and increase drowsiness—avoid during treatment.
Grapefruit juice Possible increased side effects, though not a major concern at typical dietary intakes.

Indications

Indication Status Comment
Migraine headache (with or without aura) Approved Main use in Australia
Cluster headache Off-label Occasionally prescribed by neurologists
Other headache syndromes Not approved Safety/efficacy not established

Dosing According to Clinical Indication

Population Initial Dose Max Daily Dose Notes
Adults 2.5 mg (oral/tablet or Rapimelt) 10 mg (as two 5 mg doses) May repeat after 2 hours if needed
Paediatric (12–17 years) Not routinely recommended Specialist decision only Safety data limited
Elderly (65+) 2.5 mg 5 mg Start low; monitor closely
Renal or hepatic impairment 1.25–2.5 mg 5 mg Dose adjustment required

Safety Profile / Side Effects

Frequency Side Effect
Common (>1%)
  • Drowsiness, fatigue
  • Dizziness
  • Heaviness, tingling, or warmth (chest/throat)
  • Nausea, dry mouth
Uncommon
  • Increased blood pressure
  • Palpitations
Rare
  • Serious allergic reaction (rash, swelling, difficulty breathing)
  • Serotonin syndrome symptoms
  • Heart attack or stroke (mainly in high-risk patients)

Warnings: Discontinue immediately and seek urgent help if you develop chest pain, slurred speech, weakness, severe rash, or swelling.

Guidelines for Proper Use

  1. Carry Zolmitriptan with you for prompt use at migraine onset.
  2. Do not exceed two doses in 24 hours, and leave at least 2 hours between doses.
  3. Always check expiry date, especially for Rapimelt forms stored in bags or warm areas.
  4. If you use Zolmitriptan often (more than 10 days/month), discuss with your GP—overuse can lead to “medication overuse headache”.
  5. Keep hydrated and avoid alcohol during attacks.
  6. Chronic or severe migraine should be managed in consultation with your GP or a neurologist.

Alternative Treatment Options

  • Other triptans: Sumatriptan, Rizatriptan, Naratriptan (PBS-subsidised for eligible patients; similar efficacy, differences in onset/duration and side effect profiles)
  • Simple analgesics: Paracetamol, ibuprofen (best for mild/moderate attacks; over-the-counter options; less effective at stopping severe migraines)
  • Prophylactic medicines: Beta-blockers, antiepileptics (for frequent or very disabling migraines; specialist prescription)
  • Non-drug measures: Rest, ice packs, avoiding triggers, sleep hygiene, regular meals

Pros of Zolmitriptan: Rapid relief, suitable for nausea (Rapimelt), effective for most patients resistant to simple painkillers.
Cons: Not suitable for prevention, may cause chest symptoms, limited use in cardiovascular disease.

Legal, Registration, and Reimbursement Status in Australia

  • Registration Authority: Therapeutic Goods Administration (TGA), Department of Health and Aged Care
  • Legal Status: Prescription only (Schedule 4)
  • Reimbursement (PBS): Zolmitriptan and other triptans are subsidised under the Pharmaceutical Benefits Scheme for eligible patients under specific criteria (migraine, with failed response to alternatives).
  • Pharmacist supply: Only with a valid prescription from your GP or specialist. Not available over-the-counter.

Latest Research and Clinical Guidance (2022–2025)

  • Australian & New Zealand Headache Society (2022–2024): Recommends triptans, including zolmitriptan, as first-line for moderate–severe acute migraine where simple analgesics are inadequate.
  • Cochrane Review (2023): Confirms zolmitriptan is as effective as sumatriptan; Rapimelt offers advantage in migraineurs with gastrointestinal symptoms.
  • Safety update (TGA 2024): No new significant safety risks identified, though continued caution in those with cardiovascular risk factors is advised.
  • New England Journal of Medicine (2024): Reinforces the importance of early administration at attack onset for best results.

Availability and Delivery

Pack Size Form Indicative PBS/retail price* (AUD)
6 tablets Oral tablet (2.5 mg or 5 mg) $25–$40 (PBS subsidised: $6.70 concessional, $42.50 general — subject to variation)
6 Rapimelt tablets Orodispersible $30–$50
*Prices as of June 2024. Check with your local pharmacy for up-to-date details.
City Indicative Delivery Time (in-stock prescription)
Sydney Same day – 1 working day (script ready)
Melbourne Same day – 1 working day
Brisbane 1–2 working days
Perth, Adelaide 2–3 working days
Rural/remote Up to 1 week

Frequently Asked Questions (FAQ)

1. Can I use Zolmitriptan for prevention of migraines?

No. Zolmitriptan is an “abortive” (acute) therapy only—take it at the onset of a migraine attack, not regularly for prevention.

2. Is it safe to combine Zolmitriptan with my other medicines?

Many medicines can interact with Zolmitriptan. Always give your pharmacist a full list of your regular medicines, including herbal supplements and antidepressants. Avoid use with other triptans, ergotamines, or certain antidepressants without consulting your doctor.

3. How quickly does Zolmitriptan work?

Most people notice relief within 1 hour. Rapimelt tablets may work slightly faster, especially if taken on an empty stomach.

4. What should I do if I accidentally take too much?

Seek medical advice immediately. Overdose may cause severe headache, heart symptoms, confusion, or changes in blood pressure.

5. Can I take Zolmitriptan while pregnant or breastfeeding?

Use only if advised by your doctor. Safety in pregnancy and breastfeeding is not well established—your clinician will weigh the risks and benefits based on your individual situation.


For further advice, prescription services, or migraine management support, please contact your GP, community pharmacist, or a neurologist who specialises in headache disorders.

Additional information

Dosage: No selection

5mg

Package: No selection

1 bottle, 2 bottle, 3 bottle, 4 bottle, 5 bottle